Immunoprotein is an immunologically active protein, which provides immunity against pathogenic organisms or substances. These proteins form the integrated body system of tissues, organs, cells, or cell products that neutralize antigens. They enable the diagnosis of various diseases, such as cardiovascular, oncology, infectious diseases, and others, as they display an abnormal increase in their concentration when in a diseased state.

Highlights

The global Immunoprotein Diagnostic Testing market was valued at US$ 17160 million in 2022 and is anticipated to reach US$ 24200 million by 2029, witnessing a CAGR of 5.9% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The increasing use of immunochromatography-based cassette kits or test strips is estimated to be one of the primary growth drivers for the global immunoprotein diagnostic testing market till 2023. Immunochromatography is the chromatographic method of immunoassay. It follows the lateral flow testing. It helps in the detection of infectious diseases, oncology, and autoimmune diseases using immunoproteins. The principle behind the working of immunochromatography is similar to the enzyme-linked immunosorbent assay (ELISA) test. These tests and reagents will improve the efficiency of diagnosis of diseases. Furthermore, several companies are investing heavily in research and developmental activities to develop products that reduce the time required to generate results.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Immunoprotein Diagnostic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunoprotein Diagnostic Testing.

The Immunoprotein Diagnostic Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Immunoprotein Diagnostic Testing market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Immunoprotein Diagnostic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.


By Company


Beckman Coulter

DiaSorin

F. Hoffmann-La Roche

Siemens Healthineers


Segment by Type


C-reactive Protein Diagnostic Test

Complement System Protein Diagnostic Test

Prealbumin Diagnostic Test

Haptoglobin Diagnostic Test

Immunoglobulin Diagnostic Test

Free Light Chain Diagnostic Test

Others


Segment by Application


Autoimmune Testing

Infectious Disease Testing

Allergy Testing

Endocrine Testing

Oncology Testing

Toxicology Testing

Others

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Immunoprotein Diagnostic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.